RecruitingNot Applicable

Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors

Czechia300 participantsStarted 2022-01-01

Plain-language summary

In this study, the researchers want to focus on the prevalence of anti-HEV antibodies by a new generation test, direct detection of HEV RNA, and its genotypic analysis in a group of human tissue and cell donors.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- patients indicated for organ or cell donation Exclusion Criteria: \- none

What they're measuring

Prevalence of Hepatitis E in the study groups

Timeframe: 2 years

Trial details

NCT IDNCT06457438

SponsorUniversity Hospital Ostrava

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12

Contact for this trial

Jiří Hynčica

0042059737 jiri.hyncica@fno.cz

View on ClinicalTrials.gov More Hepatitis E trials